1-2

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Corona was established by a group of committed and experienced professionals who came together with care and quality as their guiding principles. Their vision was to go beyond the norm and provide the best quality affordable healthcare for all. Today, when it comes to quality, availability and affordability of medicines, we have gone beyond just growth and turned into a force to reckon within an extremely short span of time.

Started in 1978, apex laboratories has been under the able leadership of Mr.S.S.Vanangamudi who is heading the company as the Chairman & Managing Director.  The company is a pioneer in the introduction of Zinc based formulations in India and continues to be the brand leader in the Multivitamin Mineral Supplements segment.

SMS Lifesciences India Limited is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic and Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. It has a strong research and manufacturing team supported by state of the art facilities. SMS Lifesciences is growing up from single product manufacturing to multi-product manufacturing.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Chanakya College of Pharmacy And Medical Sciences (CCPMS) was established under the umbrella of Chanakya Foundation in 2019 with aim to produce competent pharmacists catering to the needs of Industry, Academia, Research and Society.  The college is Affiliated to the Aryabhatta Knowledge University, Patna and Diploma in Pharmacy Committee, Department of Health, Govt. of Bihar.

Vital Pharma is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes. Vital Therapeutics & Formulations is designed to meet International Regulatory requirements such as CGMP, WHO, ISO 9001 & FSSC 22000 and recognised for abiding to vigorous quality and service standards for product development, analytical services, packaging and regulatory services.

SNB College of Pharmacy And Management was established under the umbrella of SNB Foundation in 2020 with aim to produce competent pharmacists catering to the needs of Industry, Academia, Research and Society.  The college is Affiliated to the Aryabhatta Knowledge University, Patna and Diploma in Pharmacy Committee, Department of Health, Govt. of Bihar. SNB is approved and recognized by various Governing bodies, including , Pharmacy Council of India (PCI), Aryabhatta Knowledge University, Patna and as well as Department of Health, Govt. Of Bihar.

Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013.